CIK 0001812360 · <br>Emerging growth company
FOXO TECHNOLOGIES INC.
Sign in to watch- Tickers
- FOXO FOXOW
- Exchange
- OTC
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851050265
- Phone
- (612) 800-0059
- Business address
- 477 SOUTH ROSEMARY AVENUE, SUITE 224, WEST PALM BEACH, FL, 33401
- Former names
- Delwinds Insurance Acquisition Corp.
Securities
- FOXO Common stock OTC
- FOXOW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-15 | Poole Andrew J. Director | Option exercise | +198,260 | 0 | ||
| 2022-09-15 | Poole Andrew J. Director | Option exercise | +198,260 | 0 | ||
| 2022-09-15 | Poole Andrew J. Director | Other acquisition · Warrants | +42,500 | $11.50 | $489K | 0 |
| 2022-09-15 | Danielson Tyler Chief Technology Officer | Grant or award | +17,425 | 17,425 | ||
| 2022-09-15 | Danielson Tyler Chief Technology Officer | Grant or award | +760,000 | 777,425 | ||
| 2022-09-15 | Danielson Tyler Chief Technology Officer | Grant or award · Stock Option (right to buy) | +52,275 | 52,275 | ||
| 2022-09-15 | Danielson Tyler Chief Technology Officer | Grant or award · Stock Option (right to buy) | +3,729 | 3,729 | ||
| 2022-09-15 | Danielson Tyler Chief Technology Officer | Grant or award · Stock Option (right to buy) | +2 | 2 | ||
| 2022-09-15 | Potashnick Robert Chief Financial Officer | Grant or award | +510,000 | 510,000 | ||
| 2022-09-15 | Potashnick Robert Chief Financial Officer | Grant or award · Stock Option (right to buy) | +78,413 | 78,413 | ||
| 2022-09-15 | Potashnick Robert Chief Financial Officer | Grant or award · Stock Option (right to buy) | +3,571 | 3,571 | ||
| 2022-09-15 | Potashnick Robert Chief Financial Officer | Grant or award · Stock Option (right to buy) | +2 | 2 | ||
| 2022-09-15 | Khaleghi Murdoc Director | Grant or award | +130,000 | 130,000 | ||
| 2022-09-15 | Khaleghi Murdoc Director | Grant or award · Stock Option (right to buy) | +40,368 | 40,368 | ||
| 2022-09-15 | Khaleghi Murdoc Director | Grant or award · Stock Option (right to buy) | +17,425 | 17,425 | ||
| 2022-09-15 | Will Michael General Counsel | Grant or award | +510,000 | 510,000 | ||
| 2022-09-15 | Will Michael General Counsel | Grant or award · Stock Option (right to buy) | +50,437 | 50,437 | ||
| 2022-09-15 | Will Michael General Counsel | Grant or award · Stock Option (right to buy) | +3,250 | 3,250 | ||
| 2022-09-15 | Will Michael General Counsel | Grant or award · Stock Option (right to buy) | +2 | 2 | ||
| 2022-09-15 | Sabes Jon CEO, Chairman | Grant or award | +372,680 | 372,680 |
Page 2 of 3 · 55 trades